CYP2D6 and Parkinson disease: Studies suggest that although the expression of CYP2D6 enzyme levels increases with age, PD patients demonstrate a 40% reduction in its expression compared to those with a healthy brain [91], potentially compromising their ability to deactivate neurotoxins associated with pathology.